Endovascular Presence of Viable Chlamydia pneumoniaeIs a Common Phenomenon in Coronary Artery Disease 11This study was supported in part by the Research Commission of the Medical University of Lübeck (8/96) and the Deutsche Forschungsgemeinschaft (SFB 367/B2), Bonn, Germany.
Open Access
- 24 March 1998
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 31 (4) , 827-832
- https://doi.org/10.1016/s0735-1097(98)00016-3
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Cardiovascular disease risk from prior Chlamydia pneumoniae infection can be related to certain antigens recognized in the immunoblot profileJournal of Infection, 1997
- Atheroma: more than mushThe Lancet, 1996
- Chlamydia pneumoniae Pneumonia in Hospitalized PatientsChest, 1996
- Failure to Detect Chlamydia pneumoniae in Coronary Atheromas of Patients Undergoing AtherectomyThe Journal of Infectious Diseases, 1996
- Chlamydia pneumoniae (TWAR)Clinical Microbiology Reviews, 1995
- Chlamydia pneumoniae: Risk factors for seropositivity and association with coronary heart diseaseJournal of Infection, 1995
- Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart StudyAnnals of Internal Medicine, 1992
- Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1988
- A NewChlamydia psittaciStrain, TWAR, Isolated in Acute Respiratory Tract InfectionsNew England Journal of Medicine, 1986